arrow
K

Keith J. Chappell

The University of Queensland
H指数:27
被引数:2,974

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and Immunogenicity of a Severe Acute Respiratory Syndrome Coronavirus 2 Spike Subunit Vaccine Stabilized in the Prefusion Conformation by a Second-Generation Molecular Clamp and Evaluated in Adults Aged 18-55 Years: A Randomized, Double-Blind, Active Comparator, Phase I Trial

一项利用第二代分子夹稳定前融合构象的严重急性呼吸综合征冠状病毒2刺突亚单位疫苗的安全性与免疫原性研究:一项在18-55岁成人中进行的随机、双盲、活性对照、I期临床试验

2025-12-010
PRE
Nipah virus vaccines evaluated in pigs as a ‘One Health’ approach to protect public health

尼帕病毒疫苗在猪中的评估作为一种“一种健康”方法来保护公共卫生

2025-07-230
OAAI
A nanobody-based therapeutic targeting Nipah virus limits viral escape

靶向尼帕病毒的基于纳米抗体的治疗剂限制了病毒逃逸

2025-07-080
PRE
Evolution of KoRV-A transcriptional silencing in wild koalas

野生考拉中KoRV-A转录沉默的演变

CELL
IF42.5
2025-04-010
PRE
Long-term safety and immunogenicity of an MF59- adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or >56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial
2023-11-011
OAAI
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
2022-11-0189
OAAI
A platform technology for generating subunit vaccines against diverse viral pathogens

用于产生针对多种病毒病原体的亚单位疫苗的平台技术

2022-08-1811
OAAI
Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants

用于检测不同SARS-CoV-2变体的核衣壳特异性诊断

2022-06-1013
OAAI